Profilo
Jeff Hammel worked as a Controller at Eli Lilly & Co. and as a Chief Financial Officer at Orthofix Medical, Inc. He also served as the Chief Financial Officer at Kuur Therapeutics Ltd.
from 2013 to 2018.
Precedenti posizioni note di Jeff Hammel
Società | Posizione | Fine |
---|---|---|
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Direttore Finanziario/CFO | 16/02/2018 |
ELI LILLY AND COMPANY | Comptroller/Controller/Auditor | - |
ORTHOFIX MEDICAL INC. | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ORTHOFIX MEDICAL INC. | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Aziende private | 1 |
---|---|
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Jeff Hammel